title: Reply: Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation.
authors: Nikolaus
authors: N
authors: Sarafoff
authors: Robert A
authors: RA
authors: Byrne
authors: Julinda
authors: J
authors: Mehilli
authors: Dirk
authors: D
authors: Sibbing
authors: Steen D
authors: SD
authors: Kristensen
authors: Karl-Ludwig
authors: KL
authors: Laugwitz
authors: Michael
authors: M
authors: Maeng
authors: Adnan
authors: A
authors: Kastrati
mesh_terms: D001241:Aspirin / Q000008:administration & dosage*; D054855:Drug-Eluting Stents; D005260:Female; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D013988:Ticlopidine / Q000031:analogs & derivatives*
chemical_list: D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine; D001241:Aspirin